Skip to main content

Shifting Perspectives: Implicating Microglia in the Development of Schizophrenia Pathogenesis



Schizophrenia is a disorder of high complexity in which many neural pathways present aberrant signaling. ­­­In fact, this is true in the symptoms that are presented as it is arguably one of the most heterogenous disorders, with symptoms ranging from hallucinations to flat affect. As changes in the dopaminergic, serotonergic, cholinergic, glutamatergic, and GABAergic systems are present, not one singular factor has been identified as the root cause. On a more macroscopic scale, structural abnormalities are seen such as decreased brain volumes and enlarged ventricles1
            Currently, there is no singular genetic variant or environmental factor in which the development of schizophrenia can be attributed. Rather, the prevailing understanding is that schizophrenia arises through sets of gene by environment interactions over long periods of time. Being that the pathophysiology is so heterogeneous in systems as well as across patients, this variance may be attributed to an accumulation of these interactions over a lifetime. 
            Recent research has pointed to several roles microglia play in driving this pathophysiology1–5. A more recent endeavor in understanding the basis of schizophrenia amongst other disorders, as more studies are published linking the neuroimmune function of these cells to pathology, the conversation and hypothesis surrounding these disorders is being reframed. Microglia, the resident immune macrophage-like cells in the brain oversee much of the processes that remove debris from the brain as well as prune under-active synapses4. As these cells begin their lineage in the yolk sac, they are persistent throughout neural development. Therefore, much research is being done to look at the long-term effects alterations in microglia can have in the brain when affected by genetic and environmental factors. 
            As more and more studies implicate microglia in the development of schizophrenia, this cell type should be included more conversations regarding neuropathology. It is the case that many studies rely only on neuronal genetics, physiology, and morphology where it may be helpful to bring microglial function into the conversation. Overall, the sheer utility of microglia as a cell type is changing many understandings of disorders such as schizophrenia and giving much insight into how they develop.


Works Cited 
1.         Jaaro-Peled, H., Ayhan, Y., Pletnikov, M. V. & Sawa, A. Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models. Schizophr. Bull. 36, 301–313 (2010).
2.         Wang, M., Zhang, L. & Gage, F. H. Microglia, complement and schizophrenia. Nat. Neurosci. 22, 333–334 (2019).
3.         Tay, T. L. et al. Microglia Gone Rogue: Impacts on Psychiatric Disorders across the Lifespan. Front. Mol. Neurosci. 10, (2018).
4.         Nayak, D., Roth, T. L. & McGavern, D. B. Microglia Development and function. Annu. Rev. Immunol.32, 367–402 (2014).
5.         Sellgren, C. M. et al. Increased microglial synapse elimination in patient-specific models of schizophrenia. http://biorxiv.org/lookup/doi/10.1101/231290 (2017) doi:10.1101/231290.

Comments

Popular posts from this blog

Gut-Brain Interactions: Buffington et al, Reber et al 2016

April 13 Papers (Buffington et. al, Reber et. al) I found this week’s papers to be quite novel in that they both proposed potential treatments for neurodevelopmental or psychiatric disorders that target bacterial or microbial abnormalities and how these give rise to certain behavioral and physical symptoms associated with the disorders. I thought this was a very unusual yet interesting approach, and as I have not previously studied the gut-brain axis, these papers offered me a fresh perspective on researching psychiatric and neurodevelopmental disorders. They were also unconventional in their focus of the physical symptoms that often accompany mental disorders, as this is not something that I have seen many other papers touch upon very much. Particularly, I was surprised by the Reber et al paper’s focus on the link between psychiatric disorders and inflammation in organs other than the brain, such as the colon, and the Buffington et al paper’s description of a relationship between ...

Buffington et al. and Reber et al.: Gut-Brain Interactions

While I have not encountered a lot of gut-brain interaction literature yet. I found each paper unique and fascinating. Reber et al felt inaccessible for me. I felt like I didn’t understand what the goal of the paper really was and why they did the tests that they did. It seems like most of their relevant information got shoved into numerous supplementary figures and their behavior was quite difficult to follow. Multiple sections of their paper were supported with data found entirely in supplementary figures, which makes it difficult to follow the same conclusions. I have a few issues with the behavior they chose and because of this, I struggle to find driving conclusions from their work. I don’t understand why the CSC was not only the prior stressor but was also the acute stress condition both groups faced. To me, I feel like it would have made more sense to have the CSC be the prior stressor and then judge the effect on social behavior with maybe a three choice chamber test or te...

Buffington et al (2016) and Reber et al. (2016)

This week's articles were about the role of the gut-brain axis in neurodevelopment and stress. Reber and colleagues used a heat-killed version of the bacteria, M. vaccae, as a type of vaccine and found that administration to mouse models resulted in decreased response to chronic stress, prevented colitis related to stress, and reduced measures of anxiety. Reber et al. also used the inactivated M. vaccae in a mouse model of IBD and found that the bacteria prevented stress-induce flare-ups of colitis, but that this could be reversed by removing T cells. Buffington and colleagues instead examined the role of gut microbiota in maternal high-fat diets (MHFD) in the neurodevelopment and social behaviors of their offspring. Buffington et al. found that housing MHFD rats with the offspring of regular diet (MRD) rats prevented social deficits in their offspring. They also found that this co-housing arrangement prevented an imbalance in the gut bacteria Reber and colleagues' findings w...